Serum hepcidin was found to be greatly increased in patients with inflammation defined as CRP >10mg/dL, patients with sepsis, burns, inflammatory bowel disease, and multiple myeloma [13,3537]. diagnosis of different forms of anemia will be facilitated by improved hepcidin assays, and the treatment will be enhanced by the development of hepcidin agonists and antagonists. == 1. Hepcidin-Ferroportin Conversation Regulates Iron Homeostasis == Hepcidin GSK2807 Trifluoroacetate is usually a small peptide hormone secreted by hepatocytes, circulating in blood plasma and excreted in urine [1]. Like other peptide hormones, hepcidin is usually synthesized initially as a larger 84-amino acid preprohepcidin then processed in hepatocytes by the signal peptidase to 60-amino acid prohepcidin that lacks iron-regulatory activity [2]. Prior to secretion, prohormone convertases cleave prohepcidin at a polybasic motif to generate the mature bioactive 25-amino acid hepcidin [3]. Other cell types including macrophages and adipocytes also contain hepcidin mRNA but their local and systemic contribution to the production of bioactive hepcidin has not been established with certainty. Hepcidin plays an essential role in maintaining iron homeostasis, and the dysregulation of its production underlies many iron disorders. Chronic excess of hepcidin causes iron-restricted anemia [4], whereas hepcidin deficiency results in iron overload with iron deposition in the liver and other parenchyma [5]. Hepcidin acts by regulating the cellular concentration of its receptor, ferroportin. Ferroportin is the single known cellular iron exporter and is essential for iron homeostasis [6]. This multispanning membrane protein is expressed in tissues which transport large amounts of iron (Physique 1): duodenal enterocytes which absorb dietary iron, macrophages of the spleen and liver which recycle iron from old erythrocytes, hepatocytes which store and release iron according to body needs, and placental trophoblast which transports iron from GSK2807 Trifluoroacetate maternal to fetal circulation [79]. == Physique 1. == Hepcidin-ferroportin conversation determines the flow of iron into plasma. Hepcidin concentration is in turn regulated by iron, erythropoietic activity, and inflammation. When ferroportin is located in the cell membrane it allows efflux of iron from the cells into plasma. Hepcidin binding to GSK2807 Trifluoroacetate the extracellular face of ferroportin triggers internalization and degradation of the ligand-receptor complex [10]. Removal of ferroportin from the membrane stops cellular iron export leading to decreased supply of iron into plasma (Physique 1). Without the constant iron influx, the plasma iron pool is usually rapidly depleted by the iron-consuming cells, most prominently erythroid precursors. In mice, a single injection of synthetic hepcidin caused a rapid drop in serum iron [11], and this lasted for 2 days, presumably until sufficient amount of ferroportin was resynthesized. Decreased ferroportin concentration in cell membranes, as seen during chronic overproduction of hepcidin, can lead to iron-restricted erythropoiesis. Interestingly, ferroportin is also expressed in erythroid precursor cells [12], but GSK2807 Trifluoroacetate its physiological role or Mouse monoclonal to CD34.D34 reacts with CD34 molecule, a 105-120 kDa heavily O-glycosylated transmembrane glycoprotein expressed on hematopoietic progenitor cells, vascular endothelium and some tissue fibroblasts. The intracellular chain of the CD34 antigen is a target for phosphorylation by activated protein kinase C suggesting that CD34 may play a role in signal transduction. CD34 may play a role in adhesion of specific antigens to endothelium. Clone 43A1 belongs to the class II epitope. * CD34 mAb is useful for detection and saparation of hematopoietic stem cells the effect of hepcidin on developing GSK2807 Trifluoroacetate erythrocytes remains to be decided. == 2. Regulation of Hepcidin == Hepcidin is usually homeostatically regulated by iron and erythropoietic activity. Increased plasma and stored iron stimulate hepcidin production, which in turn blocks dietary iron absorption and further iron loading (Physique 1). Hepcidin is usually suppressed in iron deficiency [13], allowing increased absorption of dietary iron and replenishment of iron stores. The feedback loop between iron and hepcidin ensures the stability of plasma iron concentrations. As would be expected for the iron-regulatory hormone, hepcidin production is also regulated by the process which consumes most iron, erythropoiesis [14]. Increased erythropoietic activity suppresses hepcidin production which allows the release of stored iron from macrophages and hepatocytes, and increased iron absorption, all resulting in greater supply of iron for hemoglobin synthesis. Hepcidin production is also pathologically increased in inflammation and contamination [15]. Resultant hypoferremia may represent a host defense strategy to limit iron availability to microorganisms, but can also lead to iron dysregulation and iron-restricted anemia in inflammatory diseases. == 3. Molecular Mechanisms of Hepcidin Regulation == == 3.1. Iron == Hepcidin is likely regulated by both circulating iron-transferrin and intracellular iron stores. Although the respective mechanisms of sensing extracellular and intracellular iron are not well comprehended, they both appear to utilize the bone morphogenetic protein (BMP) pathway to alter hepcidin expression. Several BMPs have been shown to increase hepcidin production in vitro and in vivo [16], but BMP6 has recently emerged as the principal endogenous BMP regulating hepcidin. BMP6 knockout mice develop severe iron overload but no other significant abnormalities [17,18]. In other biological settings, BMP signaling is known to be modulated by coreceptors and antagonists. Hemojuvelin.